ATE306817T1 - Cholin-kieselsäure-komplex mit osmolyten und divalenten spurenelementen - Google Patents

Cholin-kieselsäure-komplex mit osmolyten und divalenten spurenelementen

Info

Publication number
ATE306817T1
ATE306817T1 AT03722360T AT03722360T ATE306817T1 AT E306817 T1 ATE306817 T1 AT E306817T1 AT 03722360 T AT03722360 T AT 03722360T AT 03722360 T AT03722360 T AT 03722360T AT E306817 T1 ATE306817 T1 AT E306817T1
Authority
AT
Austria
Prior art keywords
choline
silicic acid
osmolytes
trace elements
acid complex
Prior art date
Application number
AT03722360T
Other languages
English (en)
Inventor
Berghe Dirk Andre Richa Vanden
Original Assignee
Bio Minerals Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Minerals Nv filed Critical Bio Minerals Nv
Application granted granted Critical
Publication of ATE306817T1 publication Critical patent/ATE306817T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C05—FERTILISERS; MANUFACTURE THEREOF
    • C05G—MIXTURES OF FERTILISERS COVERED INDIVIDUALLY BY DIFFERENT SUBCLASSES OF CLASS C05; MIXTURES OF ONE OR MORE FERTILISERS WITH MATERIALS NOT HAVING A SPECIFIC FERTILISING ACTIVITY, e.g. PESTICIDES, SOIL-CONDITIONERS, WETTING AGENTS; FERTILISERS CHARACTERISED BY THEIR FORM
    • C05G5/00—Fertilisers characterised by their form
    • C05G5/20—Liquid fertilisers
    • C05G5/23—Solutions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/28—Silicates, e.g. perlites, zeolites or bentonites
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C05—FERTILISERS; MANUFACTURE THEREOF
    • C05D—INORGANIC FERTILISERS NOT COVERED BY SUBCLASSES C05B, C05C; FERTILISERS PRODUCING CARBON DIOXIDE
    • C05D9/00—Other inorganic fertilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Pest Control & Pesticides (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Environmental Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
AT03722360T 2002-03-20 2003-03-20 Cholin-kieselsäure-komplex mit osmolyten und divalenten spurenelementen ATE306817T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076099A EP1371289A1 (de) 2002-03-20 2002-03-20 Cholin-Kieselsäure-Komplex
PCT/EP2003/003175 WO2003077657A1 (en) 2002-03-20 2003-03-20 Choline-silicic acid complex with osmolytes and divalent trace elements

Publications (1)

Publication Number Publication Date
ATE306817T1 true ATE306817T1 (de) 2005-11-15

Family

ID=27838106

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03722360T ATE306817T1 (de) 2002-03-20 2003-03-20 Cholin-kieselsäure-komplex mit osmolyten und divalenten spurenelementen

Country Status (12)

Country Link
US (1) US7968528B2 (de)
EP (2) EP1371289A1 (de)
JP (1) JP4642357B2 (de)
CN (2) CN1652687A (de)
AT (1) ATE306817T1 (de)
AU (1) AU2003229575B2 (de)
CA (1) CA2479659C (de)
DE (1) DE60301955T2 (de)
DK (1) DK1487272T3 (de)
ES (1) ES2251684T3 (de)
IL (1) IL164132A0 (de)
WO (1) WO2003077657A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007112733A (ja) * 2005-10-19 2007-05-10 Agro Kanesho Co Ltd 植物病虫害抑制剤及びその製造方法
GB0805279D0 (en) 2008-03-20 2008-04-30 Univ Nottingham Trent Food supplement
WO2011010188A1 (en) 2009-07-23 2011-01-27 Societe Anonyme Des Eaux Minerales D'evian "S.A.E.M.E" A process for producing water enriched with natural orthosilicic acid
EP2371220B2 (de) * 2010-03-31 2018-01-17 Taminco Stabilisierte, bioverfügbare, lösliche Silikatlösung
WO2012032364A1 (en) 2010-09-06 2012-03-15 Creogen D.O.O. Stabilized solution of ortho-silicic acid based on salicylic acid as effective inhibitor of its polymerization, its preparation and use
WO2012035364A1 (en) 2010-09-15 2012-03-22 Creogen D.O.O. Stabilized solution of ortho-silicic acid, its preparation and use
EP2720619B1 (de) 2011-06-14 2016-10-26 Cook Medical Technologies LLC Vorrichtungen für fistelverschluss
PL403902A1 (pl) * 2013-05-15 2014-11-24 Przedsiębiorstwo Intermag Spółka Z Ograniczoną Odpowiedzialnością Preparat krzemowy o właściwościach stymulujących rozwój roślin, sposób wytwarzania preparatu krzemowego stymulującego rozwój roślin i jego zastosowanie
CN104161770A (zh) * 2013-05-17 2014-11-26 蒋临沂 一种硅酸络合物
SG10202100422VA (en) 2016-08-10 2021-02-25 Res & Innovation Uk Compositions comprising nanosilica particles and their use in methods of activating t lymphocytes for therapy
IN201731033800A (de) * 2017-09-23 2019-03-29
CN111683531A (zh) * 2017-10-17 2020-09-18 Upl有限公司 新型农用化学品组合
CN112384068A (zh) * 2018-05-15 2021-02-19 丹斯塔发酵股份公司 杀真菌剂和甘氨酸甜菜碱组合用于防治真菌性植物病原体的用途
EP3632449A1 (de) * 2018-10-05 2020-04-08 Bio Minerals N.V. Kielelsäuren zur verwendung bei der behandlung von parodontitis
MX2021008769A (es) * 2019-01-24 2021-11-12 Silinnov Srcl Composición de alimento y agua potable para aves de corral que comprende un complejo de silicio estable y biodisponible.
EP3989733A1 (de) * 2019-06-28 2022-05-04 RXW Group NV Geflügelfutter- und trinkwasserzusammensetzung mit monomethylsilantriol
IT202200009089A1 (it) 2022-05-04 2023-11-04 Geofarma S R L Composizione a base di silicio biodisponibile e vitamine
CN119894823A (zh) 2022-08-02 2025-04-25 巴尔拉有限公司 稳定的硅酸溶液

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466958A (en) * 1981-03-18 1984-08-21 Morrison L M Food supplement
DE3409063A1 (de) * 1984-03-13 1985-09-19 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von fliessfaehigen cholinchlorid-kieselsaeure-pulvern
US5183061A (en) * 1988-07-22 1993-02-02 Ethyl Corporation Silicon compounds in bone treatment
DE4218768A1 (de) * 1992-06-06 1993-12-09 Basf Ag Verfahren zur Herstellung von Cholinchlorid enthaltenden Pulvern, diese Pulver und ihre Verwendung
DE4220549C1 (de) * 1992-06-24 1993-06-17 Messer Griesheim Gmbh, 6000 Frankfurt, De
US5840881A (en) * 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
DE4322939A1 (de) * 1993-07-09 1995-01-12 Bad Koestritz Chemiewerk Gmbh Mittel zur Abwehr von Umweltgiften und Pilzkrankheiten sowie zur Transpirationshemmung von Pflanzenteilen und Behandlungsverfahren
NL9400189A (nl) * 1994-02-07 1995-09-01 Bio Pharma Sciences Bv Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat.
AUPN085395A0 (en) * 1995-02-02 1995-02-23 Ab Tall (Holdings) Pty Ltd Osmolyte regulator
DE19739031A1 (de) * 1997-09-05 1999-03-11 Suwelack Nachf Dr Otto Mittel zur peroralen Verabreichung, seine Herstellung und Verwendung
FR2799758B1 (fr) * 1999-10-15 2002-05-17 Exsymol Sa Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation
EP1110909A1 (de) * 1999-12-24 2001-06-27 Bio Minerals N.V. Verfahren zur Herstellung von Orthokieselsäure, sowie nach dem Verfahren hergestellte Kieselsäure und ihre Verwendung

Also Published As

Publication number Publication date
DE60301955D1 (de) 2006-03-02
EP1487272B1 (de) 2005-10-19
ES2251684T3 (es) 2006-05-01
EP1487272A1 (de) 2004-12-22
WO2003077657A1 (en) 2003-09-25
CN1652687A (zh) 2005-08-10
US7968528B2 (en) 2011-06-28
CA2479659C (en) 2012-09-18
AU2003229575A1 (en) 2003-09-29
AU2003229575B2 (en) 2008-08-07
CA2479659A1 (en) 2003-09-25
IL164132A0 (en) 2005-12-18
DK1487272T3 (da) 2006-01-30
JP4642357B2 (ja) 2011-03-02
JP2005520822A (ja) 2005-07-14
CN101171927B (zh) 2013-05-15
EP1371289A1 (de) 2003-12-17
US20060165815A1 (en) 2006-07-27
CN101171927A (zh) 2008-05-07
DE60301955T2 (de) 2006-07-27

Similar Documents

Publication Publication Date Title
ATE306817T1 (de) Cholin-kieselsäure-komplex mit osmolyten und divalenten spurenelementen
BR9914160A (pt) Composição antigênica, método para aumentar a capacidade de uma composição antigênica que contenha um antìgeno selecionado de uma bactéria, vìrus, fungo ou parasita patogênicos, do haemophilus influenzae, do helicobacter pylori, do vìrus sincicial respiratório, do rotavìrus, e, do vìrus simples do herpes para evocar a resposta imune de um hospedeiro vertebrado, plasmìdeo, célula hospedeira, método para produzir uma holotoxina do cólera mutante imunogênica, e, uso de uma quantidade auxiliar eficaz de uma holotoxina do cólera mutante
DE60327745D1 (de) Verwendung von adapalen zur behandlung dermatologischer erkrankungen
DK0486425T3 (da) Højsyresystem af næringsformuleringer
DK1602660T3 (da) Aminophosphonsyrederivater, additionssalte deraf og S1P-receptormodulatorer
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
BR0209129A (pt) Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos
BR0011541A (pt) Suplementos nutricionais
EP1664271A4 (de) Modulation der expression von diacylglycerin-acyltransferase 2
ATE384072T1 (de) Modulation der immunostimulatorischen aktivität von immunostimulierenden oligonukleotidanaloga durch positionelle chemische veränderungen
ATE385797T1 (de) Phosphonatverbindungen
PT1191025E (pt) Cristais de lansoprazol
CY1105799T1 (el) Καινουρια προφαρμακα που πepιεχουν φωσφορο
DE60326220D1 (de) Verfahren zur herstellung von einer 2-18f-fluor-2-deoxy-d-glucose (18fdg)-lösung
BR0010590A (pt) Emprego de filanto para estimulação objetivada do sistema imunológico
BRPI0607713A2 (pt) métodos para monitorar ou detectar a conversão do ácido n-(fosfonometil) iminodiacético para n-(fosfonometil)glicina ou outro intermediário para n-(fosfonometil)glicina no curso da oxidação catalìtica de ácido n-(fosfonometil)iminodiacético em um meio aquoso
BR0012371A (pt) Sistema de caixa de câmbio com dispositivo de câmbio
DK1112747T3 (da) Salmonellavaccine, som ikke inducerer antistoffer mod flagellin eller flageller
BR0210348A (pt) Material polimérico, contendo um ácido latente
ATE237957T1 (de) Verwendung einer zusammensetzung zur versehung von glutamine
BRPI0506779A (pt) formulação de sorvete, e, sorvete
FR2881748B1 (fr) Dispersions silicones aqueuses, formulations notamment de peintures les comprenant et l'un de leurs procedes de preparation
BR0315055A (pt) Diamidas de ácido pirimidin-4,6-dicarboxìilco para a inibição seletiva de colagenases
BR0113668A (pt) Oligoelementos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1487272

Country of ref document: EP